NPPB and COVID-19: In a cohort study of 416 hospitalized COVID-19 patients, 19.7% had evidence of myocardial injury manifested by elevation of high-sensitivity troponin I levels and NT-terminal pro-B-type natriuretic peptide (NT-proBNP).